New roles for mitochondrial proteases in health, ageing and disease

Nature Reviews Molecular Cell Biology

Volumn 16, Issue 6, 2015, Pages 345-359

  Quirós, Pedro M ^a   Langer, Thomas ^b   López Otín, Carlos ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; MITOCHONDRIAL PROTEIN; PEPTIDE HYDROLASE; TUMOR PROTEIN;

AGING; APOPTOSIS; ARTICLE; BIOGENESIS; CATALYSIS; ENZYME STRUCTURE; GENETIC DISORDER; HUMAN; LIFESPAN; METABOLIC SYNDROME X; MITOCHONDRIAL DYNAMICS; MITOCHONDRION; MITOPHAGY; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN QUALITY; PROTEIN SYNTHESIS; QUALITY CONTROL; STRESS; SYSTEMIC DISEASE; ANIMAL; DEGENERATIVE DISEASE; ENZYMOLOGY; GENETICS; HUMAN GENOME; METABOLISM; PATHOLOGY;

AGING; ANIMALS; GENOME, HUMAN; HUMANS; METABOLIC SYNDROME X; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; NEOPLASM PROTEINS; NEOPLASMS; NEURODEGENERATIVE DISEASES; PEPTIDE HYDROLASES; PROTEOLYSIS;

EID: 84930040430     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm3984     Document Type: Article

References (182)

1. Turk, B., Turk, D. & Turk, V. Protease signalling: the cutting edge. EMBO J. 31, 1630-1643 (2012).
2. Lopez-Otin, C. & Bond, J. S. Proteases: multifunctional enzymes in life and disease. J. Biol. Chem. 283, 30433-30437 (2008).
3. Lopez-Otin, C. & Hunter, T. The regulatory crosstalk between kinases and proteases in cancer. Nature Rev. Cancer 10, 278-292 (2010).
4. Koppen, M. & Langer, T. Protein degradation within mitochondria: versatile activities of AAA proteases and other peptidases. Crit. Rev. Biochem. Mol. Biol. 42, 221-242 (2007).
5. Anand, R., Langer, T. & Baker, M. J. Proteolytic control of mitochondrial function and morphogenesis. Biochim. Biophys. Acta 1833, 195-204 (2013).
6. Rugarli, E. I. & Langer, T. Mitochondrial quality control: a matter of life and death for neurons. EMBO J. 31, 1336-1349 (2012).
7. Goard, C. A. & Schimmer, A. D. Mitochondrial matrix proteases as novel therapeutic targets in malignancy. Oncogene 33, 2690-2699 (2014).
8. Bulteau, A. L. & Bayot, A. Mitochondrial proteases and cancer. Biochim. Biophys. Acta 1807, 595-601 (2011).
9. Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194-1217 (2013).
10. Quesada, V., Ordonez, G. R., Sanchez, L. M., Puente, X. S. & Lopez-Otin, C. The degradome database: mammalian proteases and diseases of proteolysis. Nucleic Acids Res. 37, D239-D243 (2009).
11. Rawlings, N. D., Waller, M., Barrett, A. J. & Bateman, A. MEROPS: the database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res. 42, D503-D509 (2014).
12. Pagliarini, D. J. et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell 134, 112-123 (2008).
13. Kremmidiotis, G. et al. Molecular and functional analyses of the human and mouse genes encoding AFG3L1, a mitochondrial metalloprotease homologous to the human spastic paraplegia protein. Genomics 76, 58-65 (2001).
14. Voos, W. Chaperone-protease networks in mitochondrial protein homeostasis. Biochim. Biophys. Acta 1833, 388-399 (2013).
15. Schmidt, O., Pfanner, N. & Meisinger, C. Mitochondrial protein import: from proteomics to functional mechanisms. Nature Rev. Mol. Cell Biol. 11, 655-667 (2010).
16. Gakh, O., Cavadini, P. & Isaya, G. Mitochondrial processing peptidases. Biochim. Biophys. Acta 1592, 63-77 (2002).
17. Teixeira, P. F. & Glaser, E. Processing peptidases in mitochondria and chloroplasts. Biochim. Biophys. Acta 1833, 360-370 (2013).
18. Dvorakova-Hola, K. et al. Glycine-rich loop of mitochondrial processing peptidase a-subunit is responsible for substrate recognition by a mechanism analogous to mitochondrial receptor Tom20. J. Mol. Biol. 396, 1197-1210 (2010).
19. Nunnari, J., Fox, T. D. & Walter, P. A mitochondrial protease with two catalytic subunits of nonoverlapping specificities. Science 262, 1997-2004 (1993).
20. Ieva, R. et al. Mitochondrial inner membrane protease promotes assembly of presequence translocase by removing a carboxy-Terminal targeting sequence. Nature Commun. 4, 2853 (2013).
21. Vogtle, F. N. et al. Mitochondrial protein turnover: role of the precursor intermediate peptidase Oct1 in protein stabilization. Mol. Biol. Cell 22, 2135-2143 (2011).
22. Vogtle, F. N. et al. Global analysis of the mitochondrial N-proteome identifies a processing peptidase critical for protein stability. Cell 139, 428-439 (2009).
23. Serero, A., Giglione, C., Sardini, A., Martinez-Sanz, J. & Meinnel, T. An unusual peptide deformylase features in the human mitochondrial N-Terminal methionine excision pathway. J. Biol. Chem. 278, 52953-52963 (2003).
24. Gerdes, F., Tatsuta, T. & Langer, T. Mitochondrial AAA proteases-Towards a molecular understanding of membrane-bound proteolytic machines. Biochim. Biophys. Acta 1823, 49-55 (2012).
25. Koppen, M., Metodiev, M. D., Casari, G., Rugarli, E. I. & Langer, T. Variable and tissue-specific subunit composition of mitochondrial m-AAA protease complexes linked to hereditary spastic paraplegia. Mol. Cell. Biol. 27, 758-767 (2007).
26. Stiburek, L. et al. YME1L controls the accumulation of respiratory chain subunits and is required for apoptotic resistance, cristae morphogenesis, and cell proliferation. Mol. Biol. Cell 23, 1010-1023 (2012).
27. Hornig-Do, H. T. et al. Nonsense mutations in the COX1 subunit impair the stability of respiratory chain complexes rather than their assembly. EMBO J. 31, 1293-1307 (2012).
28. Zurita Rendon, O. & Shoubridge, E. A. Early complex I assembly defects result in rapid turnover of the ND1 subunit. Hum. Mol. Genet. 21, 3815-3824 (2012).
29. Lu, B. et al. The ATP-dependent Lon protease of Mus musculus is a DNA-binding protein that is functionally conserved between yeast and mammals. Gene 306, 45-55 (2003).
30. Venkatesh, S., Lee, J., Singh, K., Lee, I. & Suzuki, C. K. Multitasking in the mitochondrion by the ATP-dependent Lon protease. Biochim. Biophys. Acta 1823, 56-66 (2012).
31. Teng, H. et al. Oxygen-sensitive mitochondrial accumulation of cystathionine b-synthase mediated by Lon protease. Proc. Natl Acad. Sci. USA 110, 12679-12684 (2013).
32. Bezawork-Geleta, A., Saiyed, T., Dougan, D. A. & Truscott, K. N. Mitochondrial matrix proteostasis is linked to hereditary paraganglioma: LON-mediated turnover of the human flavinylation factor SDH5 is regulated by its interaction with SDHA. FASEB J. 28, 1794-1804 (2014).
33. Kita, K., Suzuki, T. & Ochi, T. Diphenylarsinic acid promotes degradation of glutaminase C by mitochondrial Lon protease. J. Biol. Chem. 287, 18163-18172 (2012).
34. Fukuda, R. et al. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 129, 111-122 (2007).
35. Bota, D. A. & Davies, K. J. Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism. Nature Cell Biol. 4, 674-680 (2002).
36. Granot, Z. et al. Turnover of mitochondrial steroidogenic acute regulatory (StAR) protein by Lon protease: the unexpected effect of proteasome inhibitors. Mol. Endocrinol. 21, 2164-2177 (2007).
37. Tian, Q. et al. Lon peptidase 1 (LONP1)-dependent breakdown of mitochondrial 5-Aminolevulinic acid synthase protein by heme in human liver cells. J. Biol. Chem. 286, 26424-26430 (2011).
38. Matsushima, Y., Goto, Y. & Kaguni, L. S. Mitochondrial Lon protease regulates mitochondrial DNA copy number and transcription by selective degradation of mitochondrial transcription factor A (TFAM). Proc. Natl Acad. Sci. USA 107, 18410-18415 (2010).
39. Quiros, P. M. et al. ATP-dependent Lon protease controls tumor bioenergetics by reprogramming mitochondrial activity. Cell Rep. 8, 542-556 (2014).
40. Haynes, C. M., Petrova, K., Benedetti, C., Yang, Y. & Ron, D. ClpP mediates activation of a mitochondrial unfolded protein response in C. elegans. Dev. Cell 13, 467-480 (2007).
41. Gispert, S. et al. Loss of mitochondrial peptidase Clpp leads to infertility, hearing loss plus growth retardation via accumulation of CLPX, mtDNA and inflammatory factors. Hum. Mol. Genet. 22, 4871-4887 (2013).
42. Stahl, A. et al. Isolation and identification of a novel mitochondrial metalloprotease (PreP) that degrades targeting presequences in plants. J. Biol. Chem. 277, 41931-41939 (2002).
43. Kambacheld, M., Augustin, S., Tatsuta, T., Muller, S. & Langer, T. Role of the novel metallopeptidase Mop112 and saccharolysin for the complete degradation of proteins residing in different subcompartments of mitochondria. J. Biol. Chem. 280, 20132-20139 (2005).
44. Mossmann, D. et al. Amyloid-b peptide induces mitochondrial dysfunction by inhibition of preprotein maturation. Cell Metab. 20, 662-669 (2014).
45. Falkevall, A. et al. Degradation of the amyloid b-protein by the novel mitochondrial peptidasome, PreP. J. Biol. Chem. 281, 29096-29104 (2006).
46. Serizawa, A., Dando, P. M. & Barrett, A. J. Characterization of a mitochondrial metallopeptidase reveals neurolysin as a homologue of thimet oligopeptidase. J. Biol. Chem. 270, 2092-2098 (1995).
47. Clausen, T., Kaiser, M., Huber, R. & Ehrmann, M. HTRA proteases: regulated proteolysis in protein quality control. Nature Rev. Mol. Cell Biol. 12, 152-162 (2011).
48. Plun-Favreau, H. et al. HtrA2 deficiency causes mitochondrial uncoupling through the F1F0-ATP synthase and consequent ATP depletion. Cell Death Dis. 3, e335 (2012).
49. Osman, C., Wilmes, C., Tatsuta, T. & Langer, T. Prohibitins interact genetically with Atp23, a novel processing peptidase and chaperone for the F1F0-ATP synthase. Mol. Biol. Cell 18, 627-635 (2007).
50. Potting, C., Wilmes, C., Engmann, T., Osman, C. & Langer, T. Regulation of mitochondrial phospholipids by Ups1/PRELI-like proteins depends on proteolysis and Mdm35. EMBO J. 29, 2888-2898 (2010).
51. Almajan, E. R. et al. AFG3L2 supports mitochondrial protein synthesis and Purkinje cell survival. J. Clin. Invest. 122, 4048-4058 (2012).
52. Nolden, M. et al. The m-AAA protease defective in hereditary spastic paraplegia controls ribosome assembly in mitochondria. Cell 123, 277-289 (2005).
53. Maltecca, F. et al. Purkinje neuron Ca2+ influx reduction rescues ataxia in SCA28 model. J. Clin. Invest. 125, 263-274 (2015).
54. Rainbolt, T. K., Atanassova, N., Genereux, J. C. & Wiseman, R. L. Stress-regulated translational attenuation adapts mitochondrial protein import through Tim17A degradation. Cell Metab. 18, 908-919 (2013).
55. Potting, C. et al. TRIAP1/PRELI complexes prevent apoptosis by mediating intramitochondrial transport of phosphatidic acid. Cell Metab. 18, 287-295 (2013).
56. Lu, B. et al. Phosphorylation of human TFAM in mitochondria impairs DNA binding and promotes degradation by the AAA+ Lon protease. Mol. Cell 49, 121-132 (2013).
57. Liu, T. et al. DNA and RNA binding by the mitochondrial Lon protease is regulated by nucleotide and protein substrate. J. Biol. Chem. 279, 13902-13910 (2004).
58. Goo, H. G., Jung, M. K., Han, S. S., Rhim, H. & Kang, S. HtrA2/Omi deficiency causes damage and mutation of mitochondrial DNA. Biochim. Biophys. Acta 1833, 1866-1875 (2013).
59. Oberto, J. et al. Qri7/OSGEPL, the mitochondrial version of the universal Kae1/YgjD protein, is essential for mitochondrial genome maintenance. Nucleic Acids Res. 37, 5343-5352 (2009).
60. Polianskyte, Z. et al. LACTB is a filament-forming protein localized in mitochondria. Proc. Natl Acad. Sci. USA 106, 18960-18965 (2009).
61. Houtkooper, R. H. et al. Mitonuclear protein imbalance as a conserved longevity mechanism. Nature 497, 451-457 (2013).
62. Runkel, E. D., Liu, S., Baumeister, R. & Schulze, E. Surveillance-Activated defenses block the ROS-induced mitochondrial unfolded protein response. PLoS Genet. 9, e1003346 (2013).
63. Zhao, Q. et al. A mitochondrial specific stress response in mammalian cells. EMBO J. 21, 4411-4419 (2002).
64. Jovaisaite, V., Mouchiroud, L. & Auwerx, J. The mitochondrial unfolded protein response, a conserved stress response pathway with implications in health and disease. J. Exp. Biol. 217, 137-143 (2014).
65. Nargund, A. M., Pellegrino, M. W., Fiorese, C. J., Baker, B. M. & Haynes, C. M. Mitochondrial import efficiency of ATFS-1 regulates mitochondrial UPR activation. Science 337, 587-590 (2012).
66. Aldridge, J. E., Horibe, T. & Hoogenraad, N. J. Discovery of genes activated by the mitochondrial unfolded protein response (mtUPR) and cognate promoter elements. PLoS ONE 2, e874 (2007).
67. Wu, Y. et al. Multilayered genetic and omics dissection of mitochondrial activity in a mouse reference population. Cell 158, 1415-1430 (2014).
68. Bahat, A. et al. StAR enhances transcription of genes encoding the mitochondrial proteases involved in its own degradation. Mol. Endocrinol. 28, 208-224 (2014).
69. Moisoi, N. et al. Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response. Cell Death Differ. 16, 449-464 (2009).
70. Friedman, J. R. & Nunnari, J. Mitochondrial form and function. Nature 505, 335-343 (2014).
71. Mishra, P. & Chan, D. C. Mitochondrial dynamics and inheritance during cell division, development and disease. Nature Rev. Mol. Cell Biol. 15, 634-646 (2014).
72. Anand, R. et al. The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission. J. Cell Biol. 204, 919-929 (2014).
73. Ishihara, N., Fujita, Y., Oka, T. & Mihara, K. Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J. 25, 2966-2977 (2006).
74. Sood, A. et al. A Mitofusin-2-dependent inactivating cleavage of Opa1 links changes in mitochondria cristae and ER contacts in the postprandial liver. Proc. Natl Acad. Sci. USA 111, 16017-16022 (2014).
75. Mishra, P., Carelli, V., Manfredi, G. & Chan, D. C. Proteolytic cleavage of Opa1 stimulates mitochondrial inner membrane fusion and couples fusion to oxidative phosphorylation. Cell Metab. 19, 630-641 (2014).
76. Ehses, S. et al. Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1. J. Cell Biol. 187, 1023-1036 (2009).
77. Quiros, P. M. et al. Loss of mitochondrial protease OMA1 alters processing of the GTPase OPA1 and causes obesity and defective thermogenesis in mice. EMBO J. 31, 2117-2133 (2012).
78. Head, B., Griparic, L., Amiri, M., Gandre-Babbe, S. & van der Bliek, A. M. Inducible proteolytic inactivation of OPA1 mediated by the OMA1 protease in mammalian cells. J. Cell Biol. 187, 959-966 (2009).
79. Quiros, P. M., Ramsay, A. J. & Lopez-Otin, C. New roles for OMA1 metalloprotease: from mitochondrial proteostasis to metabolic homeostasis. Adipocyte 2, 7-11 (2013).
80. Escobar-Henriques, M. & Langer, T. Dynamic survey of mitochondria by ubiquitin. EMBO Rep. 15, 231-243 (2014).
81. Yue, W. et al. A small natural molecule promotes mitochondrial fusion through inhibition of the deubiquitinase USP30. Cell Res. 24, 482-496 (2014).
82. Nakamura, N. & Hirose, S. Regulation of mitochondrial morphology by USP30, a deubiquitinating enzyme present in the mitochondrial outer membrane. Mol. Biol. Cell 19, 1903-1911 (2008).
83. Youle, R. J. & Narendra, D. P. Mechanisms of mitophagy. Nature Rev. Mol. Cell Biol. 12, 9-14 (2011).
84. Jin, S. M. & Youle, R. J. The accumulation of misfolded proteins in the mitochondrial matrix is sensed by PINK1 to induce PARK2/Parkin-mediated mitophagy of polarized mitochondria. Autophagy 9, 1750-1757 (2013).
85. Greene, A. W. et al. Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment. EMBO Rep. 13, 378-385 (2012).
86. Jin, S. M. et al. Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J. Cell Biol. 191, 933-942 (2010).
87. Thomas, R. E., Andrews, L. A., Burman, J. L., Lin, W. Y. & Pallanck, L. J. PINK1-Parkin pathway activity is regulated by degradation of PINK1 in the mitochondrial matrix. PLoS Genet. 10, e1004279 (2014).
88. Cilenti, L. et al. Inactivation of Omi/HtrA2 protease leads to the deregulation of mitochondrial Mulan E3 ubiquitin ligase and increased mitophagy. Biochim. Biophys. Acta 1843, 1295-1307 (2014).
89. Park, H. M. et al. The serine protease HtrA2/Omi cleaves Parkin and irreversibly inactivates its E3 ubiquitin ligase activity. Biochem. Biophys. Res. Commun. 387, 537-542 (2009).
90. Xiong, H. et al. Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation. J. Clin. Invest. 119, 650-660 (2009).
91. Sekine, S. et al. Rhomboid protease PARL mediates the mitochondrial membrane potential loss-induced cleavage of PGAM5. J. Biol. Chem. 287, 34635-34645 (2012).
92. Chen, G. et al. A regulatory signaling loop comprising the PGAM5 phosphatase and CK2 controls receptor-mediated mitophagy. Mol. Cell 54, 362-377 (2014).
93. Wang, Z., Jiang, H., Chen, S., Du, F. & Wang, X. The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell 148, 228-243 (2012).
94. MacVicar, T. D. & Lane, J. D. Impaired OMA1-dependent cleavage of OPA1 and reduced DRP1 fission activity combine to prevent mitophagy in cells that are dependent on oxidative phosphorylation. J. Cell Sci. 127, 2313-2325 (2014).
95. Wang, K., Jin, M., Liu, X. & Klionsky, D. J. Proteolytic processing of Atg32 by the mitochondrial i-AAA protease Yme1 regulates mitophagy. Autophagy 9, 1828-1836 (2013).
96. Bingol, B. et al. The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy. Nature 510, 370-375 (2014).
97. Mariño, G., Niso-Santano, M., Baehrecke, E. H. & Kroemer, G. Self-consumption: the interplay of autophagy and apoptosis. Nature Rev. Mol. Cell Biol. 15, 81-94 (2014).
98. Jiang, X., Jiang, H., Shen, Z. & Wang, X. Activation of mitochondrial protease OMA1 by Bax and Bak promotes cytochrome c release during apoptosis. Proc. Natl Acad. Sci. USA 111, 14782-14787 (2014).
99. Baker, M. J. et al. Stress-induced OMA1 activation and autocatalytic turnover regulate OPA1-dependent mitochondrial dynamics. EMBO J. 33, 578-593 (2014).
100. Xiao, X. et al. OMA1 mediates OPA1 proteolysis and mitochondrial fragmentation in experimental models of ischemic kidney injury. Am. J. Physiol. Renal Physiol. 306, F1318-F1326 (2014).
101. Chao, J. R. et al. Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons. Nature 452, 98-102 (2008).
102. Suzuki, Y. et al. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol. Cell 8, 613-621 (2001).
103. Hartkamp, J., Carpenter, B. & Roberts, S. G. The Wilms' tumor suppressor protein WT1 is processed by the serine protease HtrA2/Omi. Mol. Cell 37, 159-171 (2010).
104. Sosna, J. et al. The proteases HtrA2/Omi and UCH-L1 regulate TNF-induced necroptosis. Cell Commun. Signal. 11, 76 (2013).
105. Yacobi-Sharon, K., Namdar, Y. & Arama, E. Alternative germ cell death pathway in Drosophila involves HtrA2/Omi, lysosomes, and a caspase-9 counterpart. Dev. Cell 25, 29-42 (2013).
106. Cipolat, S. et al. Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell 126, 163-175 (2006).
107. Frezza, C. et al. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 126, 177-189 (2006).
108. Bratic, A. & Larsson, N. G. The role of mitochondria in aging. J. Clin. Invest. 123, 951-957 (2013).
109. Baker, B. M. & Haynes, C. M. Mitochondrial protein quality control during biogenesis and aging. Trends Biochem. Sci. 36, 254-261 (2011).
110. Lionaki, E. & Tavernarakis, N. Oxidative stress and mitochondrial protein quality control in aging. J. Proteomics 92, 181-194 (2013).
111. Ngo, J. K. & Davies, K. J. Importance of the Lon protease in mitochondrial maintenance and the significance of declining Lon in aging. Ann. N.Y. Acad. Sci. 1119, 78-87 (2007).
112. Ngo, J. K., Pomatto, L. C. & Davies, K. J. Upregulation of the mitochondrial Lon protease allows adaptation to acute oxidative stress but dysregulation is associated with chronic stress, disease, and aging. Redox Biol. 1, 258-264 (2013).
113. Erjavec, N. et al. Deletion of the mitochondrial Pim1/Lon protease in yeast results in accelerated aging and impairment of the proteasome. Free Radic. Biol. Med. 56, 9-16 (2013).
114. Luce, K. & Osiewacz, H. D. Increasing organismal healthspan by enhancing mitochondrial protein quality control. Nature Cell Biol. 11, 852-858 (2009).
115. Fischer, F., Weil, A., Hamann, A. & Osiewacz, H. D. Human CLPP reverts the longevity phenotype of a fungal ClpP deletion strain. Nature Commun. 4, 1397 (2013).
116. Kang, S. et al. Loss of HtrA2/Omi activity in non-neuronal tissues of adult mice causes premature aging. Cell Death Differ. 20, 259-269 (2013).
117. Maltecca, F. et al. The mitochondrial protease AFG3L2 is essential for axonal development. J. Neurosci. 28, 2827-2836 (2008).
118. Lopez, L. M. et al. Evolutionary conserved longevity genes and human cognitive abilities in elderly cohorts. Eur. J. Hum. Genet. 20, 341-347 (2012).
119. Lu, B. et al. A mutation in the inner mitochondrial membrane peptidase 2-like gene (Immp2l) affects mitochondrial function and impairs fertility in mice. Biol. Reprod. 78, 601-610 (2008).
120. George, S. K., Jiao, Y., Bishop, C. E. & Lu, B. Mitochondrial peptidase IMMP2L mutation causes early onset of age-Associated disorders and impairs adult stem cell self-renewal. Aging Cell 10, 584-594 (2011).
121. George, S. K., Jiao, Y., Bishop, C. E. & Lu, B. Oxidative stress is involved in age-dependent spermatogenic damage of Immp2l mutant mice. Free Radic. Biol. Med. 52, 2223-2233 (2012).
122. Stames, E. M. & O'Toole, J. F. Mitochondrial aminopeptidase deletion increases chronological lifespan and oxidative stress resistance while decreasing respiratory metabolism in S. cerevisiae. PLoS ONE 8, e77234 (2013).
123. Koopman, W. J., Willems, P. H. & Smeitink, J. A. Monogenic mitochondrial disorders. N. Engl. J. Med. 366, 1132-1141 (2012).
124. Bonifati, V. et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299, 256-259 (2003).
125. Strauss, K. M. et al. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum. Mol. Genet. 14, 2099-2111 (2005).
126. Unal Gulsuner, H. et al. Mitochondrial serine protease HTRA2 p.G399S in a kindred with essential tremor and Parkinson disease. Proc. Natl Acad. Sci. USA 111, 18285-18290 (2014).
127. Jones, J. M. et al. Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of Mnd2 mutant mice. Nature 425, 721-727 (2003).
128. Martins, L. M. et al. Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol. Cell. Biol. 24, 9848-9862 (2004).
129. Shi, G. et al. Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease. Hum. Mol. Genet. 20, 1966-1974 (2011).
130. Yoshioka, H. et al. The role of PARL and HtrA2 in striatal neuronal injury after transient global cerebral ischemia. J. Cereb. Blood Flow Metab. 33, 1658-1665 (2013).
131. Bertelsen, B. et al. Intragenic deletions affecting two alternative transcripts of the IMMP2L gene in patients with Tourette syndrome. Eur. J. Hum. Genet. 22, 1283-1289 (2014).
132. Casey, J. P. et al. A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder. Hum. Genet. 131, 565-579 (2012).
133. Gimelli, S. et al. Interstitial 7q31.1 copy number variations disrupting IMMP2L gene are associated with a wide spectrum of neurodevelopmental disorders. Mol. Cytogenet. 7, 54 (2014).
134. Di Bella, D. et al. Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. Nature Genet. 42, 313-321 (2010).
135. Pierson, T. M. et al. Whole-exome sequencing identifies homozygous AFG3L2 mutations in a spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases. PLoS Genet. 7, e1002325 (2011).
136. Casari, G. et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93, 973-983 (1998).
137. Pfeffer, G. et al. Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance. Brain 137, 1323-1336 (2014).
138. Wedding, I. M. et al. Spastic paraplegia type 7 is associated with multiple mitochondrial DNA deletions. PLoS ONE 9, e86340 (2014).
139. Ferreirinha, F. et al. Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. J. Clin. Invest. 113, 231-242 (2004).
140. Martinelli, P. et al. Genetic interaction between the m-AAA protease isoenzymes reveals novel roles in cerebellar degeneration. Hum. Mol. Genet. 18, 2001-2013 (2009).
141. Kondadi, A. K. et al. Loss of the m-AAA protease subunit AFG3L2 causes mitochondrial transport defects and tau hyperphosphorylation. EMBO J. 33, 1011-1026 (2014).
142. Maltecca, F. et al. Haploinsufficiency of AFG3L2, the gene responsible for spinocerebellar ataxia type 28, causes mitochondria-mediated Purkinje cell dark degeneration. J. Neurosci. 29, 9244-9254 (2009).
143. Almontashiri, N. A. et al. SPG7 variant escapes phosphorylation-regulated processing by AFG3L2, elevates mitochondrial ROS, and is associated with multiple clinical phenotypes. Cell Rep. 7, 834-847 (2014).
144. Civitarese, A. E. et al. Regulation of skeletal muscle oxidative capacity and insulin signaling by the mitochondrial rhomboid protease PARL. Cell Metab. 11, 412-426 (2010).
145. Cavalcanti, D. M. et al. Neurolysin knockout mice generation and initial phenotype characterization. J. Biol. Chem. 289, 15426-15440 (2014).
146. Chen, Y. et al. Variations in DNA elucidate molecular networks that cause disease. Nature 452, 429-435 (2008).
147. Strauss, K. A. et al. CODAS syndrome is associated with mutations of LONP1, encoding mitochondrial AAA+ Lon protease. Am. J. Hum. Genet. 96, 121-135 (2015).
148. Jenkinson, E. M. et al. Perrault syndrome is caused by recessive mutations in CLPP, encoding a mitochondrial ATP-dependent chambered protease. Am. J. Hum. Genet. 92, 605-613 (2013).
149. Miyake, N. et al. Mitochondrial complex III deficiency caused by a homozygous UQCRC2 mutation presenting with neonatal-onset recurrent metabolic decompensation. Hum. Mutat. 34, 446-452 (2013).
150. O'Toole, J. F. et al. Individuals with mutations in XPNPEP3, which encodes a mitochondrial protein, develop a nephronophthisis-like nephropathy. J. Clin. Invest. 120, 791-802 (2010).
151. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
152. Wallace, D. C. Mitochondria and cancer. Nature Rev. Cancer 12, 685-698 (2012).
153. Nie, X. et al. Down-regulating overexpressed human Lon in cervical cancer suppresses cell proliferation and bioenergetics. PLoS ONE 8, e81084 (2013).
154. Cheng, C. W. et al. Overexpression of Lon contributes to survival and aggressive phenotype of cancer cells through mitochondrial complex I-mediated generation of reactive oxygen species. Cell Death Dis. 4, e681 (2013).
155. Gibellini, L. et al. Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells. FASEB J. 28, 5122-5135 (2014).
156. Bayot, A. et al. Effect of Lon protease knockdown on mitochondrial function in HeLa cells. Biochimie 100, 38-47 (2014).
157. Bernstein, S. H. et al. The mitochondrial ATP-dependent Lon protease: a novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivatives. Blood 119, 3321-3329 (2012).
158. Quir, P. M., Bocena, C. & Laez-Ota, C. Lon protease: a key enzyme controlling mitochondrial bioenergetics in cancer. Mol. Cell. Oncol. 1, e968505 (2014).
159. Yamauchi, S. et al. p53-mediated activation of the mitochondrial protease HtrA2/Omi prevents cell invasion. J. Cell Biol. 204, 1191-1207 (2014).
160. Kong, B., Wang, Q., Fung, E., Xue, K. & Tsang, B. K. p53 is required for cisplatin-induced processing of the mitochondrial fusion protein L-Opa1 that is mediated by the mitochondrial metallopeptidase Oma1 in gynecologic cancers. J. Biol. Chem. 289, 27134-27145 (2014).
161. Leszczyniecka, M. et al. MAP1D, a novel methionine aminopeptidase family member is overexpressed in colon cancer. Oncogene 25, 3471-3478 (2006).
162. Kohler, A. et al. Genome-wide association study on differentiated thyroid cancer. J. Clin. Endocrinol. Metab. 98, E1674-E1681 (2013).
163. Alikhani, N. et al. Targeting capacity and conservation of PreP homologues localization in mitochondria of different species. J. Mol. Biol. 410, 400-410 (2011).
164. Canet-Aviles, R. M. et al. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl Acad. Sci. USA 101, 9103-9108 (2004).
165. Smith, P. M., Fox, J. L. & Winge, D. R. Biogenesis of the cytochrome bc1 complex and role of assembly factors. Biochim. Biophys. Acta 1817, 276-286 (2012).
166. Miyakoshi, K. et al. The identification of novel ovarian proteases through the use of genomic and bioinformatic methodologies. Biol. Reprod. 75, 823-835 (2006).
167. Smith, M. A. & Schnellmann, R. G. Calpains, mitochondria, and apoptosis. Cardiovasc. Res. 96, 32-37 (2012).
168. Arrington, D. D., Van Vleet, T. R. & Schnellmann, R. G. Calpain 10: a mitochondrial calpain and its role in calcium-induced mitochondrial dysfunction. Am. J. Physiol. Cell Physiol. 291, C1159-C1171 (2006).
169. Krumschnabel, G., Sohm, B., Bock, F., Manzl, C. & Villunger, A. The enigma of caspase-2: the laymen's view. Cell Death Differ. 16, 195-207 (2009).
170. Lakhani, S. A. et al. Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 311, 847-851 (2006).
171. Kantari, C. & Walczak, H. Caspase-8 and bid: caught in the act between death receptors and mitochondria. Biochim. Biophys. Acta 1813, 558-563 (2011).
172. Costantini, P. et al. Pre-processed caspase-9 contained in mitochondria participates in apoptosis. Cell Death Differ. 9, 82-88 (2002).
173. Durcan, T. M. et al. USP8 regulates mitophagy by removing K6-linked ubiquitin conjugates from parkin. EMBO J. 33, 2473-2491 (2014).
174. Schwickart, M. et al. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature 463, 103-107 (2010).
175. Cornelissen, T. et al. The deubiquitinase USP15 antagonizes Parkin-mediated mitochondrial ubiquitination and mitophagy. Hum. Mol. Genet. 23, 5227-5242 (2014).
176. Fu, J. et al. Disruption of SUMO-specific protease 2 induces mitochondria mediated neurodegeneration. PLoS Genet. 10, e1004579 (2014).
177. Zunino, R., Schauss, A., Rippstein, P., Andrade-Navarro, M. & McBride, H. M. The SUMO protease SENP5 is required to maintain mitochondrial morphology and function. J. Cell Sci. 120, 1178-1188 (2007).
178. Betin, V. M., MacVicar, T. D., Parsons, S. F., Anstee, D. J. & Lane, J. D. A cryptic mitochondrial targeting motif in Atg4D links caspase cleavage with mitochondrial import and oxidative stress. Autophagy 8, 664-676 (2012).
179. Leissring, M. A. et al. Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria. Biochem. J. 383, 439-446 (2004).
180. Chow, K. M., Ma, Z., Cai, J., Pierce, W. M. & Hersh, L. B. Nardilysin facilitates complex formation between mitochondrial malate dehydrogenase and citrate synthase. Biochim. Biophys. Acta 1723, 292-301 (2005).
181. Martinvalet, D., Dykxhoorn, D. M., Ferrini, R. & Lieberman, J. Granzyme A cleaves a mitochondrial complex I protein to initiate caspase-independent cell death. Cell 133, 681-692 (2008).
182. Han, J. et al. Deregulation of mitochondrial membrane potential by mitochondrial insertion of granzyme B and direct Hax-1 cleavage. J. Biol. Chem. 285, 22461-22472 (2010).